G1 Therapeutics, Inc.·4

Mar 4, 4:54 PM ET

Moses Jennifer K. 4

4 · G1 Therapeutics, Inc. · Filed Mar 4, 2021

Insider Transaction Report

Form 4
Period: 2021-03-03
Moses Jennifer K.
VP of Finance & Admin
Transactions
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2021-03-033,000333 total
    Exercise: $3.72Exp: 2025-12-21Common Stock (3,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-03$3.72/sh+3,000$11,16025,000 total
Footnotes (2)
  • [F1]Represents 14,000 shares of common stock and 11,000 restricted stock units
  • [F2]All shares underlying this option have vested.

Documents

2 files